Biocardia Inc. (BCDA) Q4 2024 Earnings Call Transcript: Detailed Analysis of Biocardia’s Profit-Driven Q4 Performance
BioCardia, Inc. (NASDAQ: BCDA ) Q4 2024 Earnings Conference Call: A Detailed Analysis On March 31, 2025, at 4:30 PM ET, BioCardia, Inc. (NASDAQ: BCDA ), a leading company in the cardiovascular regenerative therapies industry, held its Q4 2024 earnings conference call. The call was attended by several analysts and investors, including Joe Pantginis from…